Portfolio Holdings Detail for ISIN IE00BYVJRR92

Stock Name / Fund	iShares MSCI USA SRI UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	SUUS(GBX) LSE
ETF Ticker	QDVR(EUR) F
ETF Ticker	QDVR.DE(EUR) CXE
ETF Ticker	SUAS.LS(USD) CXE
ETF Ticker	SUASz(USD) CXE
ETF Ticker	SUAU.AS(EUR) CXE
ETF Ticker	SUAS(EUR) ETF Plus
ETF Ticker	SUAU(EUR) Euronext Amsterdam
ETF Ticker	SUUS.L(GBP) LSE

Holdings detail for SOLV

Show aggregate SOLV holdings

News associated with SOLV

Wells Fargo & Company Issues Positive Forecast for Solventum (NYSE:SOLV) Stock Price

Solventum (NYSE:SOLV – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from $79.00 to $82.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of […] - 2025-09-17 03:06:58

Solventum Completes Sale Of Purification & Filtration Business; Raises Annual Earnings Outlook

(RTTNews) - Solventum Corporation (SOLV) Tuesday said that it has completed the sale of its Purification & Filtration business to Thermo Fisher Scientific Inc. (TMO) for $4 billion in cash. - 2025-09-02 10:10:37

Solventum (NYSE:SOLV) Rating Increased to Strong-Buy at Wall Street Zen

Solventum (NYSE:SOLV – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Monday. Several other equities research analysts have also issued reports on SOLV. KeyCorp started coverage on Solventum in a report on Friday, June 6th. They set a […] - 2025-09-01 03:10:44

Solventum (NYSE:SOLV) Stock Rating Lowered by Wall Street Zen

Solventum (NYSE:SOLV – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. A number of other brokerages have also recently commented on SOLV. Morgan Stanley upgraded shares of Solventum from an “equal weight” rating to […] - 2025-08-24 06:14:43

Solventum Corporation (NYSE:SOLV) Shares Sold by Maryland State Retirement & Pension System

Maryland State Retirement & Pension System lessened its stake in Solventum Corporation (NYSE:SOLV – Free Report) by 18.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,479 shares of the company’s stock after selling 1,439 shares during the quarter. Maryland State Retirement […] - 2025-08-15 04:51:01

Solventum Announces Pricing Of Secondary Offering Of 8.80 Mln Common Stock

(RTTNews) - Solventum Corp. (SOLV) announced the pricing of the secondary offering of 8.80 million shares of its common stock, which is expected to result in gross proceeds of about $648 million to 3M Company. All of the shares of common stock are being sold by the Selling Shareh - 2025-08-14 00:33:56

Solventum Corporation (NYSE:SOLV) Shares Purchased by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. boosted its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 2.2% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,173,960 shares of the company’s stock after buying an additional 24,762 shares during the quarter. Charles Schwab Investment Management […] - 2025-08-13 05:10:47

Blair William & Co. IL Sells 552 Shares of Solventum Corporation (NYSE:SOLV)

Blair William & Co. IL lessened its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 4.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 11,010 shares of the company’s stock after selling 552 shares during the period. Blair William & Co. IL’s holdings in Solventum were worth $837,000 at […] - 2025-08-11 06:24:58

Federated Hermes Inc. Trims Position in Solventum Corporation (NYSE:SOLV)

Federated Hermes Inc. trimmed its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 67.6% in the first quarter, Holdings Channel.com reports. The institutional investor owned 764 shares of the company’s stock after selling 1,595 shares during the quarter. Federated Hermes Inc.’s holdings in Solventum were worth $58,000 as of its most recent filing with […] - 2025-08-11 05:04:58

Solventum (NYSE:SOLV) Price Target Raised to $94.00

Solventum (NYSE:SOLV – Free Report) had its price objective upped by Piper Sandler from $87.00 to $94.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other equities analysts also recently weighed in on the company. Morgan Stanley raised Solventum from […] - 2025-08-11 03:08:46

XTX Topco Ltd Grows Stock Position in Solventum Corporation (NYSE:SOLV)

XTX Topco Ltd lifted its position in Solventum Corporation (NYSE:SOLV – Free Report) by 26.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,417 shares of the company’s stock after purchasing an additional 1,356 shares during the quarter. XTX Topco Ltd’s […] - 2025-08-08 04:38:55

Noteworthy Thursday Option Activity: AKAM, EXPE, SOLV

Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Akamai Technologies Inc (Symbol: AKAM), where a total of 8,566 contracts have traded so far, representing approximately 856,600 underlying shares. That amounts to about 5 - 2025-08-07 14:17:28

Financial Analysis: Solventum (NYSE:SOLV) and BG Medicine (OTCMKTS:BGMD)

BG Medicine (OTCMKTS:BGMD – Get Free Report) and Solventum (NYSE:SOLV – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Valuation & Earnings This table compares BG Medicine and […] - 2025-08-05 02:41:00

Solventum Corporation (NYSE:SOLV) Receives $84.38 Average Target Price from Brokerages

Shares of Solventum Corporation (NYSE:SOLV – Get Free Report) have earned an average rating of “Hold” from the eleven brokerages that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-08-01 02:50:51

Universal Beteiligungs und Servicegesellschaft mbH Buys 584 Shares of Solventum Corporation (NYSE:SOLV)

Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Solventum Corporation (NYSE:SOLV – Free Report) by 1.1% during the 1st quarter, Holdings Channel reports. The firm owned 53,143 shares of the company’s stock after purchasing an additional 584 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Solventum were worth $4,041,000 at the […] - 2025-07-29 05:22:58

7,059 Shares in Solventum Corporation (NYSE:SOLV) Purchased by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd acquired a new stake in Solventum Corporation (NYSE:SOLV – Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The fund acquired 7,059 shares of the company’s stock, valued at approximately $537,000. Several other institutional investors have also added to or reduced their stakes […] - 2025-07-28 06:02:51

New York State Common Retirement Fund Reduces Holdings in Solventum Corporation (NYSE:SOLV)

New York State Common Retirement Fund lowered its position in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 24.1% during the first quarter, Holdings Channel reports. The fund owned 67,549 shares of the company’s stock after selling 21,500 shares during the quarter. New York State Common Retirement Fund’s holdings in Solventum were worth $5,136,000 […] - 2025-07-22 07:09:10

Solventum Corporation (NYSE:SOLV) Shares Sold by Cwm LLC

Cwm LLC cut its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 13.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,875 shares of the company’s stock after selling 2,420 shares during the period. Cwm LLC’s holdings in Solventum […] - 2025-07-21 05:18:49

Cerity Partners LLC Buys 1,294 Shares of Solventum Corporation (NYSE:SOLV)

Cerity Partners LLC grew its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 2.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 47,466 shares of the company’s stock after buying an additional 1,294 shares during the quarter. Cerity Partners […] - 2025-07-18 04:55:04

Solventum Corporation (NYSE:SOLV) Shares Sold by Arizona State Retirement System

Arizona State Retirement System trimmed its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 0.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 42,466 shares of the company’s stock after selling 173 shares during the period. Arizona […] - 2025-07-17 05:51:11

Morgan Stanley Upgrades Solventum (NYSE:SOLV) to Overweight

Solventum (NYSE:SOLV – Get Free Report) was upgraded by research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research report issued on Tuesday, Marketbeat.com reports. The brokerage presently has a $103.00 target price on the stock, up from their prior target price of $80.00. Morgan Stanley’s price target […] - 2025-07-17 05:00:52

Solventum Corporation (NYSE:SOLV) Shares Sold by Stratos Wealth Partners LTD.

Stratos Wealth Partners LTD. lessened its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 50.6% in the 1st quarter, Holdings Channel reports. The firm owned 4,256 shares of the company’s stock after selling 4,355 shares during the period. Stratos Wealth Partners LTD.’s holdings in Solventum were worth $324,000 at the end of […] - 2025-07-16 04:58:53

Solventum Corporation (NYSE:SOLV) Shares Sold by D.A. Davidson & CO.

D.A. Davidson & CO. lowered its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 11.8% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,478 shares of the company’s stock after selling 1,002 shares during the period. D.A. Davidson & CO.’s holdings in Solventum were worth […] - 2025-07-11 05:26:54

Solventum Corporation (NYSE:SOLV) Receives $81.50 Average Price Target from Analysts

Shares of Solventum Corporation (NYSE:SOLV – Get Free Report) have been assigned an average rating of “Hold” from the eleven research firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to […] - 2025-07-07 02:06:56

Solventum Corporation (NYSE:SOLV) Position Lessened by Cambridge Investment Research Advisors Inc.

Cambridge Investment Research Advisors Inc. reduced its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 4.5% during the 1st quarter, HoldingsChannel reports. The firm owned 18,893 shares of the company’s stock after selling 895 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Solventum were worth $1,437,000 as of its most recent […] - 2025-07-04 04:32:51

Sumitomo Mitsui Trust Group Inc. Sells 586 Shares of Solventum Corporation (NYSE:SOLV)

Sumitomo Mitsui Trust Group Inc. reduced its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 0.2% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 319,689 shares of the company’s stock after selling 586 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Solventum were worth $24,309,000 at the end of […] - 2025-07-03 05:35:09

Robeco Institutional Asset Management B.V. Purchases 2,544 Shares of Solventum Corporation (NYSE:SOLV)

Robeco Institutional Asset Management B.V. lifted its position in Solventum Corporation (NYSE:SOLV – Free Report) by 8.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 31,238 shares of the company’s stock after purchasing an additional 2,544 shares during the quarter. Robeco Institutional Asset Management […] - 2025-07-02 06:14:53

Mirae Asset Global Investments Co. Ltd. Decreases Position in Solventum Corporation (NYSE:SOLV)

Mirae Asset Global Investments Co. Ltd. cut its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 5.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,617 shares of the company’s stock after selling 3,174 shares […] - 2025-07-02 05:35:01

Perigon Wealth Management LLC Acquires 159 Shares of Solventum Corporation (NYSE:SOLV)

Perigon Wealth Management LLC raised its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 3.8% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,352 shares of the company’s stock after acquiring an additional 159 shares during the quarter. Perigon Wealth […] - 2025-07-01 05:09:18

Solventum Corporation (NYSE:SOLV) Shares Purchased by Sequoia Financial Advisors LLC

Sequoia Financial Advisors LLC increased its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 137.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,344 shares of the company’s stock after purchasing an additional 10,027 shares during the quarter. […] - 2025-06-30 06:10:48

iShares MSCI USA SRI UCITS ETF USD (Acc) SOLV holdings

Share Trades of SOLV by Blackrock for IE00BYVJRR92

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-05-27	SELL	-30	72.530	72.580	72.575	USD -2,177	72.05 Loss of -16 on sale
2025-05-23	SELL	-390	70.810	72.400	72.241	USD -28,174	72.07 Loss of -66 on sale
2025-05-21	SELL	-150	72.760	73.680	73.588	USD -11,038	72.06 Loss of -229 on sale
2025-05-19	SELL	-50	75.770	75.970	75.950	USD -3,798	72.01 Loss of -197 on sale
2025-05-15	SELL	-60	72.940	73.045	73.034	USD -4,382	71.99 Loss of -63 on sale
2025-05-14	SELL	-60	71.140	73.115	72.917	USD -4,375	71.99 Loss of -55 on sale
2025-05-13	SELL	-30	73.520	74.905	74.766	USD -2,243	71.98 Loss of -84 on sale
2025-05-12	SELL	-90	74.800	75.710	75.619	USD -6,806	71.96 Loss of -329 on sale
2025-05-09	SELL	-27	70.230	71.085	70.999	USD -1,917	71.97 Profit of 26 on sale
2025-05-08	SELL	-360	66.630	67.760	67.647	USD -24,353	72.02 Profit of 1,574 on sale
2025-04-30	SELL	-240	66.120	66.310	66.291	USD -15,910	72.32 Profit of 1,448 on sale
2025-04-28	SELL	-1,170	66.070	66.670	66.610	USD -77,934	72.43 Profit of 6,815 on sale
2025-04-25	BUY	150	66.070	67.350	67.222	USD 10,083	72.49
2025-04-23	SELL	-64	65.900	68.290	68.051	USD -4,355	72.60 Profit of 291 on sale
2025-04-17	BUY	30	66.260	67.220	67.124	USD 2,014	72.87
2025-04-14	SELL	-60	67.800	68.080	68.052	USD -4,083	73.06 Profit of 301 on sale
2025-04-11	SELL	-30	66.190	66.516	66.483	USD -1,995	73.13 Profit of 199 on sale
2025-04-10	SELL	-30	65.170	68.170	67.870	USD -2,036	73.21 Profit of 160 on sale
2025-04-09	BUY	90	68.580	69.290	69.219	USD 6,230	73.26
2025-04-08	SELL	-90	63.010	68.130	67.618	USD -6,086	73.36 Profit of 517 on sale
2025-04-07	SELL	-360	65.320	66.980	66.814	USD -24,053	73.44 Profit of 2,387 on sale
2025-04-04	SELL	-300	66.200	69.145	68.850	USD -20,655	73.52 Profit of 1,401 on sale
2025-04-02	SELL	-540	76.620	77.750	77.637	USD -41,924	73.49 Loss of -2,241 on sale
2025-03-31	SELL	-90	76.040	76.170	76.157	USD -6,854	73.43 Loss of -246 on sale
2025-03-28	BUY	60	74.750	75.410	75.344	USD 4,521	73.41
2025-03-27	BUY	18	75.510	75.850	75.816	USD 1,365	73.39
2025-03-26	BUY	90	74.240	75.239	75.139	USD 6,763	73.38
2025-03-25	BUY	150	74.930	75.040	75.029	USD 11,254	73.36
2025-03-21	SELL	-150	73.970	74.900	74.807	USD -11,221	73.35 Loss of -219 on sale
2025-03-20	SELL	-30	74.990	80.260	79.733	USD -2,392	73.33 Loss of -192 on sale
2025-03-19	SELL	-150	76.310	76.970	76.904	USD -11,536	73.29 Loss of -542 on sale
2025-03-18	SELL	-90	75.300	76.000	75.930	USD -6,834	73.27 Loss of -239 on sale
2025-03-14	SELL	-150	74.160	74.920	74.844	USD -11,227	73.24 Loss of -241 on sale
2025-03-13	SELL	-690	72.300	75.000	74.730	USD -51,564	73.25 Loss of -1,023 on sale
2025-03-12	SELL	-30	74.010	76.180	75.963	USD -2,279	73.24 Loss of -82 on sale
2025-03-11	SELL	-180	75.890	77.825	77.631	USD -13,974	73.20 Loss of -797 on sale
2025-03-07	SELL	-810	77.930	78.490	78.434	USD -63,532	73.09 Loss of -4,332 on sale
2025-03-05	SELL	-90	77.830	79.750	79.558	USD -7,160	73.02 Loss of -588 on sale
2025-03-03	BUY	300	80.160	81.930	81.753	USD 24,526	72.85
2025-02-28	SELL	-2,190	79.750	82.810	82.504	USD -180,684	72.75 Loss of -21,357 on sale
2025-02-27	SELL	-60	83.440	84.700	84.574	USD -5,074	72.60 Loss of -718 on sale
2025-02-26	SELL	-600	84.040	85.920	85.732	USD -51,439	72.44 Loss of -7,974 on sale
2025-02-25	SELL	-510	83.560	84.970	84.829	USD -43,263	72.28 Loss of -6,398 on sale
2025-02-21	SELL	-630	73.020	74.720	74.550	USD -46,967	72.21 Loss of -1,472 on sale
2025-02-20	SELL	-1,110	74.500	74.900	74.860	USD -83,095	72.18 Loss of -2,975 on sale
2025-02-19	SELL	-1,170	73.980	75.192	75.071	USD -87,833	72.15 Loss of -3,415 on sale
2025-02-13	SELL	-1,260	74.310	74.365	74.359	USD -93,693	72.01 Loss of -2,954 on sale
2025-02-12	SELL	-420	73.680	73.800	73.788	USD -30,991	71.99 Loss of -756 on sale
2025-02-11	SELL	-270	73.650	75.070	74.928	USD -20,231	71.96 Loss of -801 on sale
2025-02-10	SELL	-30	74.310	74.800	74.751	USD -2,243	71.92 Loss of -85 on sale
2025-02-07	SELL	-630	73.380	74.990	74.829	USD -47,142	71.89 Loss of -1,848 on sale
2025-02-06	SELL	-30	74.780	76.455	76.288	USD -2,289	71.84 Loss of -133 on sale
2025-02-05	SELL	-90	74.790	75.000	74.979	USD -6,748	71.79 Loss of -287 on sale
2025-02-04	SELL	-300	74.610	74.940	74.907	USD -22,472	71.74 Loss of -950 on sale
2025-02-03	SELL	-360	73.580	74.319	74.245	USD -26,728	71.71 Loss of -914 on sale
2025-01-29	SELL	-540	74.500	75.365	75.278	USD -40,650	71.54 Loss of -2,021 on sale
2025-01-28	SELL	-570	74.880	76.290	76.149	USD -43,405	71.47 Loss of -2,668 on sale
2025-01-24	SELL	-60	74.990	74.990	74.990	USD -4,499	71.32 Loss of -220 on sale
2025-01-23	SELL	-60	73.600	73.830	73.807	USD -4,428	71.27 Loss of -152 on sale
2025-01-22	SELL	-210	73.660	74.250	74.191	USD -15,580	71.22 Loss of -624 on sale
2025-01-16	SELL	-240	72.690	72.930	72.906	USD -17,497	71.01 Loss of -456 on sale
2025-01-14	SELL	-120	70.190	70.385	70.366	USD -8,444	71.00 Profit of 76 on sale
2025-01-13	SELL	-270	68.510	68.570	68.564	USD -18,512	71.07 Profit of 675 on sale
2025-01-08	SELL	-456	68.960	71.850	71.561	USD -32,632	71.29 Loss of -122 on sale
2025-01-02	SELL	-240	65.930	66.740	66.659	USD -15,998	71.45 Profit of 1,149 on sale
2024-12-30	SELL	-240	66.050	66.650	66.590	USD -15,982	71.61 Profit of 1,204 on sale
2024-12-10	SELL	-60	69.720	70.980	70.854	USD -4,251	71.66 Profit of 49 on sale
2024-12-09	BUY	180	70.630	71.390	71.314	USD 12,837	71.69
2024-12-04	BUY	30	70.260	71.180	71.088	USD 2,133	71.88
2024-12-02	SELL	-116	71.990	72.380	72.341	USD -8,392	71.91 Loss of -49 on sale
2024-11-27	BUY	90	72.480	72.805	72.773	USD 6,550	71.88
2024-11-26	SELL	-120	71.490	71.990	71.940	USD -8,633	71.90 Loss of -5 on sale
2024-11-22	SELL	-210	70.810	70.940	70.927	USD -14,895	71.97 Profit of 218 on sale
2024-11-21	SELL	-60	69.630	69.930	69.900	USD -4,194	72.08 Profit of 131 on sale
2024-11-19	BUY	150	67.050	67.480	67.437	USD 10,116	72.57
2024-11-18	SELL	-723	67.120	67.430	67.399	USD -48,729	72.89 Profit of 3,970 on sale
2024-11-12	BUY	60	70.700	72.250	72.095	USD 4,326	73.03
2024-11-07	BUY	540	75.070	75.420	75.385	USD 40,708	73.03
2024-11-05	BUY	450	73.160	73.510	73.475	USD 33,064	72.92
2024-11-04	SELL	-120	72.170	73.730	73.574	USD -8,829	72.99 Loss of -70 on sale
2024-11-01	SELL	-1,260	72.460	73.820	73.684	USD -92,842	73.05 Loss of -797 on sale
2024-10-31	BUY	270	72.580	73.880	73.750	USD 19,912	73.11
2024-10-30	SELL	-90	73.570	74.120	74.065	USD -6,666	73.04 Loss of -92 on sale
2024-10-29	SELL	-2,010	73.350	73.870	73.818	USD -148,374	72.99 Loss of -1,658 on sale
2024-10-28	SELL	-60	73.360	73.550	73.531	USD -4,412	72.92 Loss of -37 on sale
2024-10-25	SELL	-2,220	73.190	73.940	73.865	USD -163,980	72.85 Loss of -2,248 on sale
2024-10-24	SELL	-240	73.200	76.050	75.765	USD -18,184	72.74 Loss of -727 on sale
2024-10-23	SELL	-30	72.500	72.690	72.671	USD -2,180	72.85 Profit of 6 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SOLV

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy